NCCM
ONCY

Nine Chapters Capital Management’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Nine Chapters Capital Management’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-52,700
Closed -$26K – 1336
2015
Q2 		$26K Sell
52,700
-50,200
-49% -$34.1K ﹤0.01% 924
2015
Q1 		$76K Buy
+102,900
New +$66K 0.01% 913
2014
Q4 		– Sell
-11,000
Closed -$6K – 1350
2014
Q3 		$6K Buy
+11,000
New +$13.9K ﹤0.01% 969

Other funds holding ONCY

VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Nine Chapters Capital Management's ONCY Position: Q3 2015 in Review

Nine Chapters Capital Management sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q3 2015, closing a stake of 52,700 shares — an estimated $26K sold.

Nine Chapters Capital Management first reported a position in ONCY in Q3 2014 and held it in 3 quarters. The position peaked at $76K in Q1 2015. 27 funds tracked by Wall St. Rank hold ONCY as of Q3 2015.

  • Nine Chapters Capital Management reported no remaining ONCOLYTICS BIOTECH INC position as of Q3 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 52,700 ONCOLYTICS BIOTECH INC shares in Q3 2015, an estimated $26K.
  • Nine Chapters Capital Management first reported a position in ONCOLYTICS BIOTECH INC in Q3 2014 and held it in 3 quarters.
  • Nine Chapters Capital Management's ONCOLYTICS BIOTECH INC position peaked at $76K in Q1 2015.
  • 27 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2015.

Based on Nine Chapters Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.